The fact that the CCR3 expression is upregulated in circulating monocytes of osteoporotic individuals with low bone mineral density (26) and in peripheral blood leukocytes in patients with RA (27) suggests that the receptor is involved in the disturbed bone remodeling process. Here, CCR3 is linked to rheumatoid arthritis.